throbber
Goodman
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`Trademark Trial and Appeal Board
`P.O. Box 1451
`Alexandria, VA 22313-1451
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Mailed: June 20, 2008
`
`Opposition No. 91181702
`
`Ther-Rx Corporation
`
`
`
`
`
`v.
`
`TherOx, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
`
`Before Hohein, Rogers and Cataldo, Administrative Trademark
`Judges.
`
`By the Board:
`
`This case now comes up on the following motions:
`
`1) Applicant’s motion to dismiss for failure to state a
`claim or alternative motion to strike, filed February
`15, 2008; and
`
`
`2) Opposer’s motion to amend the notice of opposition,
`filed March 10, 2008.
`
`
`
`
`
`
` We turn first to applicant’s motion to dismiss for
`
`failure to state a claim.
`
`In order to avoid dismissal for failure to state a
`
`claim under Fed.R.Civ.P. 12(b)(6) opposer need only allege
`
`such facts as would, if proved, establish that opposer is
`
`entitled to the relief sought. Therefore, opposer must
`
`allege that (1) it has standing to bring the proceeding, and
`
`(2) a valid ground exists for denying the registration
`
`sought. See TBMP § 503.02 (2d ed. rev. 2004).
`
`

`
`Applicant argues that this proceeding should be
`
`dismissed for failure to plead standing because opposer did
`
`not “claim any common law-rights as a Basis for Opposition”
`
`and opposer is not the owner of the pleaded registration,
`
`Reg. No. 2948813.
`
`
`
`Opposer, while admitting lack of ownership of pleaded
`
`Reg. No. 2948813, argues that its allegation in the first
`
`sentence of paragraph 3 of the notice of opposition is an
`
`assertion of common law rights and “an independent basis”
`
`for standing “sufficient to defeat the Motion to Dismiss.”
`
`
`
`We find that the allegation in paragraph 3 of the
`
`notice of opposition that “Opposer Ther-Rx is the owner of
`
`the mark THER-RX for pharmaceutical products” is a
`
`sufficient allegation of common law rights in the mark THER-
`
`RX, which if proved, would establish opposer’s standing.
`
`
`
`In view thereof, applicant’s motion to dismiss is
`
`denied.
`
`
`
`We turn next to applicant’s alternative motion to
`
`strike and opposer’s motion to amend the notice of
`
`opposition to add a joint opposer.
`
`
`
`Applicant seeks to strike the second sentence of
`
`paragraph 3 of the notice of opposition that “Opposer is
`
`further the owner of U.S. Registration No. 2,948,813 for THE
`
`THER-RX CONTINUUM OF WOMEN’S CARE & Design for ‘supplements;
`
`prenatal nutritional supplements, vitamins and
`
`2
`
`

`
`pharmaceutical and therapeutic substances, oral
`
`contraceptives, anti-infective, electrolytes, fertility
`
`enhancement preparations and agents, anti-inflammatories,
`
`nausea treatment preparations and agents, hormones,
`
`analgesics, migraine treatment preparations, muscle
`
`relaxants, nausea treatment preparations and agents for the
`
`treatment of a wide variety of illnesses, diseases and
`
`medical conditions, namely, neonatal conditions,
`
`osteoporotic conditions, aging, migraines, hypokalemia,
`
`menopause, fungal and microbial infections, virological
`
`infections, infertility, conception, osteoporosis, muscle
`
`pain, hormone replacement therapy, and morning sickness’
`
`(collectively ‘Opposer’s THER-RX Mark’)” since opposer is
`
`not the owner of the registration.
`
`
`
`In response, opposer advises that its pleading of
`
`ownership of Reg. No. 2948813, was an inadvertent mistake
`
`made in good faith and that the “undisputed owner” thereof
`
`is opposer’s “sister company,” DrugTech Corporation.
`
`Opposer seeks to maintain the second sentence of paragraph 3
`
`of the notice of opposition and “to cure Opposer’s
`
`inadvertent misidentification of itself as owner of
`
`Registration no. 2,948,813” by amending the notice of
`
`opposition to add DrugTech Corporation as a joint opposer.
`
`
`
`With regard to opposer’s motion to amend to join
`
`DrugTech Corporation as a party opposer, we note that
`
`3
`
`

`
`joinder is not allowable under these circumstances. Once a
`
`timely notice of opposition has been filed, and the time to
`
`oppose has expired, the right to pursue the filed case is a
`
`right individual to the timely filer. After commencement
`
`of the case, this right to oppose in certain circumstances
`
`may be transferred, but it may not be shared. SDT Inc. v.
`
`Patterson Dental Co., 30 USPQ2d 1707 (TTAB 1994).1 Joinder
`
`in this case would essentially allow DrugTech Corporation to
`
`file an untimely notice of opposition, which is not
`
`permitted. Accordingly, opposer’s motion to amend the
`
`notice of opposition to join DrugTech Corporation as party
`
`opposer is denied.
`
`
`
`With regard to applicant’s motion to strike, we agree
`
`that the second sentence in paragraph 3 of the notice of
`
`opposition should be stricken inasmuch as opposer is not the
`
`owner of Reg. No. 2948813. In view thereof, applicant’s
`
`motion to strike is granted and the second sentence in
`
`paragraph 3 of the notice of opposition is hereby stricken.
`
`
`
`In summary, applicant’s motion to dismiss and opposer’s
`
`motion to amend are denied and applicant’s motion to strike
`
`is granted.
`
`
`1 Prior to commencement of an opposition, a party in privity with
`a potential opposer who has obtained an extension of time to
`oppose may join with the potential opposer and seek further
`extensions or join with the opposer in filing the opposition.
`Such circumstances are not presented by this proceeding.
`Further, sister corporations are not generally held to be in a
`
`4
`
`

`
`
`
`Proceedings are resumed.
`
`We note that applicant has already filed its answer.
`
`The discovery conference, disclosures, discovery and trial
`
`dates are reset as follows:
`
`Deadline for Discovery Conference
`Discovery Opens
`Initial Disclosures Due
`Expert Disclosures Due
`Discovery Closes
`Plaintiff's Pretrial Disclosures
`Plaintiff's 30-day Trial Period Ends
`Defendant's Pretrial Disclosures
`Defendant's 30-day Trial Period Ends
`Plaintiff's Rebuttal Disclosures
`Plaintiff's 15-day Rebuttal Period Ends
`
`
`
`7/18/08
`7/18/08
`8/17/08
`12/15/08
`1/14/09
`2/28/09
`4/14/09
`4/29/09
`6/13/09
`6/28/09
`7/28/09
`
`In each instance, a copy of the transcript of testimony
`
`together with copies of documentary exhibits, must be served
`
`on the adverse party within thirty days after completion of
`
`the taking of testimony. Trademark Rule 2.l25.
`
`Briefs shall be filed in accordance with Trademark
`
`Rules 2.128(a) and (b). An oral hearing will be set only
`
`upon request filed as provided by Trademark Rule 2.l29.
`
`
`
`
`
`
`
`
`
`
`
`* * * *
`
`The USPTO published a notice of final rulemaking in the
`Federal Register on August 1, 2007, at 72 F.R. 42242. By
`this notice, various rules governing Trademark Trial and
`Appeal Board inter partes proceedings are amended. Certain
`amendments have an effective date of August 31, 2007, while
`most have an effective date of November 1, 2007. For
`further information, the parties are referred to a reprint
`of the final rule and a chart summarizing the affected
`rules, their changes, and effective dates, both viewable on
`the USPTO website via these web addresses:
`
`privity relationship, as are parent and subsidiary or assignor
`and assignee.
`
`
`5
`
`

`
`http://www.uspto.gov/web/offices/com/sol/notices/72fr42242.pdf
`http://www.uspto.gov/web/offices/com/sol/notices/72fr42242_FinalRuleChart.pdf
`
`By one rule change effective August 31, 2007, the Board's
`standard protective order is made applicable to all TTAB
`inter partes cases, whether already pending or commenced on
`or after that date. However, as explained in the final rule
`and chart, this change will not affect any case in which any
`protective order has already been approved or imposed by the
`Board. Further, as explained in the final rule, parties are
`free to agree to a substitute protective order or to
`supplement or amend the standard order even after August 31,
`2007, subject to Board approval. The standard protective
`order can be viewed using the following web address:
`http://www.uspto.gov/web/offices/dcom/ttab/tbmp/stndagmnt.htm
`
`
`6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket